All News

March 4, 2025

Signature Science selected for GSA Unrestricted OASIS+ Research and Development Contract

AUSTIN, TEXAS – March 04, 2025 - Signature Science, LLC is a recipient of an award under the General Services Administration (GSA) Unrestricted OASIS+ (One Acquisition Solution for Integrated Services Plus) contract vehicle. The company has a prime award in the Research and Development domain.OASIS+ is a “Best-in-Class” (BIC) government-wide,... MORE
February 25, 2025

Signature Science Achieves ISO/IEC 17025:2017 Accreditation for Massively Parallel Sequencing (MPS)

Achievement builds on Company’s forensic science laboratory’s accreditation scope and expands its accredited offerings into the Forensic Genetic Genealogy space. AUSTIN, TEXAS – February 25, 2025 – Signature Science’s Advanced Genomics Laboratory has been issued accreditation by ANAB, the ANSI National Accreditation Board, to the ISO/IEC 17025:2017 quality standard as... MORE
February 10, 2025

Horizon Newsletter – February 2025

Laboratory Leadership at AAFS Documentary standards play a critical role in ensuring consistency, quality, and credibility in forensic science. Hosted in collaboration with Travis County Medical Examiner's Office, our Deep-Dive session at AAFS will explore the importance of standards development, how the process works, and the benefits of becoming actively... MORE
January 29, 2025

Report Details Signature Science Contributions to LMI Group’s Efforts to Authenticate  “Elimar” (1889)

January 29, 2025 • A press release issued by LMI Group International, Inc. detailed the conclusion of multi-year, interdisciplinary investigation to authenticate a painting and attribute it to the artist, Vincent van Gogh. The investigation combined traditional authentication and innovative scientific methods. During the investigation, a hair was found embedded in the painting.... MORE
January 2, 2025

An Investigation of Downstream Processing Methods for Challenging Skeletal Samples

Abstract: While skeletal remains are known for their resilience and often serve as the final source of information for unidentified human remains (UHRs), the traditional downstream processing of these samples is challenging due to their low template nature, DNA degradation, and the presence of PCR inhibitors, typically resulting in limited... MORE
November 5, 2024

HORIZON Newsletter – November 2024

Sample mixtures and the ability to deconvolute SNP profiles present a challenge for investigations using FGG. These mixtures are common in forensics, however, database search algorithms utilized for FGG only accommodate single-source SNP profiles. To address this gap, NBFAC and Signature Science have collaborated to implement a workflow which enables... MORE
Text: rplanes, silhouette of a face with viruses coming out of mouth
October 8, 2024

PLANES: Plausibility Analysis of Epidemiological Signals

Abstract: Methods for reviewing epidemiological signals are necessary to building and maintaining data-driven public health capabilities. We have developed a novel approach for assessing the plausibility of infectious disease forecasts and surveillance data. The PLANES (PLausibility ANalysis of Epidemiological Signals) methodology is designed to be multi-dimensional and flexible, yielding an overall score based... MORE
October 5, 2024

An Interview with Friends who Found Each Other Through Forensic Science

In October, we sat down with Natalie Collins, Belinda Reyes, and Samantha Guigliemi, analysts in our Forensic Laboratory in Austin, TX. These three share a close friendship that has flourished in their time a Signature Science. We wanted to get them together to chat, pick their brains, and learn about... MORE
TEI REX Phase 2
September 3, 2024

IARPA Awards Signature Science $3.8M for Phase 2 of TEI-REX Program

Signature Science will optimize the performance of its novel biodosimetry approach developed in Phase 1 AUSTIN, TEXAS – September 3, 2024 – The Intelligence Advanced Research Projects Activity (IARPA) has selected the team led by Signature Science to advance to Phase 2 of its Targeted Evaluation of Ionizing Radiation Exposure... MORE